TruAlt Bioenergy

  • Market Cap: Small Cap
  • Industry: Commodity Chemicals
  • ISIN: INE0MWH01014
  • NSEID: TRUALT
  • BSEID: 544545
INR
372.00
-4.3 (-1.14%)
BSENSE

Mar 05

BSE+NSE Vol: 91.48 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039792,
    "name": "TruAlt Bioenergy",
    "stock_name": "TruAlt Bioenergy",
    "full_name": "TruAlt Bioenergy Ltd",
    "name_url": "stocks-analysis/trualt-bioenergy",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "372.00",
    "chg": -4.3,
    "chgp": "-1.14%",
    "dir": -1,
    "prev_price": "376.30",
    "mcapval": "3,227.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544545,
    "symbol": "TRUALT",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE0MWH01014",
    "curr_date": "Mar 05",
    "curr_time": "",
    "bse_nse_vol": "91.48 k",
    "exc_status": "Active",
    "traded_date": "Mar 05, 2026",
    "traded_date_str": "2026 03 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/trualt-bioenergy-10039792-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "TruAlt Bioenergy Downgraded to Strong Sell Amid Technical Weakness and Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trualt-bioenergy-downgraded-to-strong-sell-amid-technical-weakness-and-flat-financials-3872913",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TruAltBioenergy_mojoScore_3872913.png",
        "date": "2026-03-05 08:35:31",
        "description": "TruAlt Bioenergy Ltd, a player in the Commodity Chemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 4 March 2026. This shift reflects deteriorating technical indicators, flat financial performance, and waning institutional interest, signalling caution for investors amid challenging market conditions."
      },
      {
        "title": "TruAlt Bioenergy Ltd Faces Mildly Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-ltd-faces-mildly-bearish-momentum-amid-technical-downgrade-3872773",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TruAltBioenergy_technicaldot_3872773.png",
        "date": "2026-03-05 08:05:29",
        "description": "TruAlt Bioenergy Ltd, a player in the Commodity Chemicals sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish outlook. Recent technical indicators, including MACD, RSI, and moving averages, suggest increasing downside pressure, prompting a downgrade in its MarketsMOJO grade to Strong Sell as of 4 March 2026."
      },
      {
        "title": "TruAlt Bioenergy Ltd Faces Technical Momentum Shift Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-ltd-faces-technical-momentum-shift-amid-market-pressure-3868511",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/TruAltBioenergy_technicaldot_3868511.png",
        "date": "2026-03-04 08:08:45",
        "description": "TruAlt Bioenergy Ltd, a player in the Commodity Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a challenging market environment. The stock’s recent price action, combined with key technical indicators, signals a sideways trend with bearish undertones, prompting a downgrade in its investment grade and raising concerns among investors."
      },
      {
        "title": "TruAlt Bioenergy Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trualt-bioenergy-ltd-is-rated-sell-3852617",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TruAltBioenergy_mojoScore_3852617.png",
        "date": "2026-02-24 10:10:48",
        "description": "TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "TruAlt Bioenergy Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trualt-bioenergy-ltd-is-rated-sell-3834842",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TruAltBioenergy_mojoScore_3834842.png",
        "date": "2026-02-12 10:10:49",
        "description": "TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 February 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "TruAlt Bioenergy Gains 13.35%: 4 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-gains-1335-4-key-factors-driving-the-weeks-volatility-3825503",
        "imagepath": "",
        "date": "2026-02-07 09:00:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens week at Rs.380.05 amid broad market weakness</p>\n                    <p><strong>3 Feb:</strong> Strong rebound with 6.33% gain to Rs.404.10</p>\n                    <p><strong>4 Feb:</strong> Intraday low hit at Rs.366.35 amid price pressure and margin concerns</p>\n                    <p><strong>5 Feb:</strong> Recovery with 6.63% gain to Rs.407.95 following stabilised quarterly results</p>\n                    <p><strong>6 Feb:</strong> Intraday high of Rs.445 and 7.4% surge closes week at Rs.431.80</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-labe..."
      },
      {
        "title": "TruAlt Bioenergy Ltd Hits Intraday High with 7.4% Surge on 6 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-ltd-hits-intraday-high-with-74-surge-on-6-feb-2026-3824573",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TruAltBioenergy_priceRelatedfactors_3824573.png",
        "date": "2026-02-06 15:48:18",
        "description": "TruAlt Bioenergy Ltd recorded a robust intraday performance on 6 Feb 2026, surging 7.4% to touch a day’s high of Rs 445, significantly outperforming the Commodity Chemicals sector and broader market indices."
      },
      {
        "title": "Are TruAlt Bioenergy Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-trualt-bioenergy-ltd-latest-results-good-or-bad-3821089",
        "imagepath": "",
        "date": "2026-02-04 19:24:35",
        "description": "TruAlt Bioenergy Ltd's latest financial results for Q3 FY26 present a complex picture of operational performance. The company achieved a notable revenue growth of 520.96% quarter-on-quarter, reaching ₹713.24 crores, which reflects a strong recovery in demand within the commodity chemicals sector. Year-on-year, revenue also grew by 71.82%, indicating a positive trend in sales performance compared to the previous year.\n\nHowever, this significant top-line growth did not translate into proportional profitability. The net profit for the quarter was reported at ₹69.33 crores, which, while representing a substantial quarter-on-quarter increase of 282.74%, showed a decline of 7.79% compared to the same quarter last year. This suggests that despite higher sales, the company's ability to convert revenue into profit has weakened.\n\nThe operating margin for TruAlt Bioenergy has come under pressure, decreasing to 18.79% ..."
      },
      {
        "title": "TruAlt Bioenergy Reports Stabilised Quarterly Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-reports-stabilised-quarterly-performance-amid-margin-pressures-3820583",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TruAltBioenergy_fintrenddot_3820583.png",
        "date": "2026-02-04 11:00:20",
        "description": "TruAlt Bioenergy Ltd has reported a flat financial performance for the quarter ended December 2025, signalling a stabilisation after a period of negative trends. While revenue and profitability metrics have shown notable growth compared to the previous four-quarter averages, recent margin pressures and subdued six-month PAT growth highlight ongoing challenges for the commodity chemicals player."
      }
    ],
    "total": 33,
    "sid": "10039792",
    "stock_news_url": "https://www.marketsmojo.com/news/trualt-bioenergy-10039792"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "13-Feb-2026",
      "details": "Transcript of the Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter and nine months ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Monitoring Agency Report",
      "datetime": "10-Feb-2026",
      "details": "Trualt Bioenergy Limited has informed the exchange about Monitoring Agency Report for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "09-Feb-2026",
      "details": "Please find enclosed the audio recording link of Investors/ analysts earning call held today i.e. February 9 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

TruAlt Bioenergy Gains 13.35%: 4 Key Factors Driving the Week’s Volatility

2026-02-07 09:00:08

Key Events This Week

2 Feb: Stock opens week at Rs.380.05 amid broad market weakness

3 Feb: Strong rebound with 6.33% gain to Rs.404.10

4 Feb: Intraday low hit at Rs.366.35 amid price pressure and margin concerns

5 Feb: Recovery with 6.63% gain to Rs.407.95 following stabilised quarterly results

6 Feb: Intraday high of Rs.445 and 7.4% surge closes week at Rs.431.80

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

13-Feb-2026 | Source : BSE

Transcript of the Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter and nine months ended December 31 2025

Monitoring Agency Report

10-Feb-2026 | Source : BSE

Trualt Bioenergy Limited has informed the exchange about Monitoring Agency Report for the quarter ended December 31 2025.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

09-Feb-2026 | Source : BSE

Please find enclosed the audio recording link of Investors/ analysts earning call held today i.e. February 9 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available